Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Pazopanib bulk supplier for pharma manufacturers

Pazopanib 200mg, 400mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 200mg, 400mg

Reference Brands: Votrient

Category: Oncology Cancer Care

Pazopanib is a tyrosine kinase inhibitor (TKI) used in the treatment of advanced renal cell carcinoma (kidney cancer) and soft tissue sarcoma. It works by inhibiting multiple tyrosine kinases involved in tumor growth and angiogenesis (the formation of new blood vessels), thereby slowing or stopping the progression of cancer.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Pazopanib — third party manufacturing & bulk supply

Pazopanib 200mg, 400mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Pazopanib is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Pazopanib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Pazopanib →
Back to Listing

Frequently Asked Questions

Pazopanib is listed as Tablets in 200mg, 400mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Pazopanib is referenced against Votrient. Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Decitabine

Strength:
5mg/ml

Form: Injection

Reference Brands: Dacogen (USA)

View Details
Flutamide

Strength:
125mg, 250mg

Form: Tablets / Capsules

Reference Brands: Eulexin (USA/EU), Cytomid (EU)

View Details
Cabozantinib

Strength:
20 mg, 40 mg, 60 mg, 80mg, 100mg

Form: Tablets / Capsules

Reference Brands: Cometriq (USA), Cabometyx (USA/EU)

View Details
Triptorelin

Strength:
3.75 mg, 11.25 mg, 22.5 mg,

Form: Injection

Reference Brands: Trelstar (USA), Triptodur (USA), Gonapeptyl (EU / UK)

View Details
Aprepitant

Strength:
125/80mg

Form: Capsules

Reference Brands: Emend (US/EU)

View Details
Axitinib

Strength:
1/5 mg

Form: Tablets

Reference Brands: Inlyta (US/EU)

View Details
Azacitidine Tablet

Strength:
200 mg, 300 mg

Form: Tablets

Reference Brands: Onureg (USA)

View Details
Bendamustine Hydrochloride

Strength:
100 mg

Form: Injection

Reference Brands: Treanda, Bendeka (US), Ribomustin (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.